Covid-19, or Coronavirus, poses serious challenges to businesses. We talk about some of them here. But the coronavirus crisis will also likely open up many avenues for fraud. After all, when the chips are down like this, the temptation to hide threats and bad results, or overpromise investors, has never been greater.
Already, one pharmaceutical company is facing a securities fraud lawsuit brought by investors, after it bragged publicly that it had developed a coronavirus vaccine.
Because of the stress and temptations from the crisis, the SEC's CorpFin division released a set of guidelines companies should consider now when they look at the risks they face. Among others, CorpFin urges companies to think about:
We just sent you an email. Please click the link in the email to confirm your subscription!